Company Filing History:

8 out of 10,754

Basf Aktiengesellschaft

patents

2 out of 84

Knoll Aktiengesellschaft

patents

Years Active: 1989-1999

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5981753 - Bis-naphthalimides for the treatment of cancer (1999-11-09),

2. 5789418 - Bis-naphthalimides for the treatment of cancer (1998-08-04),

3. 5622953 - 1-amino-3-phenoxy propane derivatives as modulator agents and their (1997-04-22),

4. 5616589 - Bis-naphthalimides for the treatment of cancer (1997-04-01),

5. 5554622 - Asymmetrically substituted bisnaphthalimides (1996-09-10),

6. 5502032 - Peptides, the preparation and use thereof (1996-03-26),

7. 5180811 - Proteins having a TNF action comprising TNF-fibromectin fusion protein (1993-01-19),

8. 5157106 - N-terminal deletions of lymphotoxin, their preparation and use (1992-10-20),

9. 4959484 - Novel strobilurine derivatives, their preparation and their use (1990-09-25),

10. 4874863 - Bisnaphthalimides (1989-10-17),

Title: The Innovative Contributions of Gerhard Keilhauer in Cancer Treatment

Introduction: Gerhard Keilhauer, based in Dannstadt-Schauernheim, Germany, is a notable inventor with a significant portfolio of ten patents. His work primarily focuses on pharmaceutical compounds, specifically in the area of cancer treatment.

Latest Patents: Among his latest innovations, Keilhauer developed bis-naphthalimides for the treatment of cancer. These compounds and their pharmaceutical compositions are disclosed to be effective in treating specific cancer types. The detailed formula includes various identified components, which play a crucial role in their preparation and application in medical treatments.

Career Highlights: Throughout his career, Keilhauer has worked with prominent companies such as BASF Aktiengesellschaft and Knoll Aktiengesellschaft. His affiliation with these organizations underscores his expertise and commitment to advancing pharmaceutical science and developing innovative treatments.

Collaborations: Keilhauer has collaborated with notable coworkers, including Cynthia A. Romerdahl and Xiao-Dong Qian. These partnerships have likely contributed to the success of his research and the impactful innovations he has brought to the pharmaceutical field.

Conclusion: Gerhard Keilhauer is a prominent figure in the realm of pharmaceutical inventions, particularly in cancer treatment. His recent patents reflect a dedicated effort to create effective therapies that have the potential to improve patient outcomes. As he continues to innovate, his contributions will remain essential in the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.